Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4WM9

Acinetobacter baumanii OXA-24 complex with Avibactam

Summary for 4WM9
Entry DOI10.2210/pdb4wm9/pdb
Related2JC7
DescriptorBeta-lactamase, (2S,5R)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carboxamide, SULFATE ION, ... (6 entities in total)
Functional Keywordsbeta-lactamase, class d carbapenemase, inhibitor, hydrolase
Biological sourceAcinetobacter baumannii
Total number of polymer chains1
Total formula weight28408.50
Authors
Mangani, S.,Benvenuti, M.,Docquier, J.-D. (deposition date: 2014-10-08, release date: 2014-12-03, Last modification date: 2024-11-06)
Primary citationLahiri, S.D.,Mangani, S.,Jahic, H.,Benvenuti, M.,Durand-Reville, T.F.,De Luca, F.,Ehmann, D.E.,Rossolini, G.M.,Alm, R.A.,Docquier, J.D.
Molecular Basis of Selective Inhibition and Slow Reversibility of Avibactam against Class D Carbapenemases: A Structure-Guided Study of OXA-24 and OXA-48.
Acs Chem.Biol., 10:591-600, 2015
Cited by
PubMed Abstract: The Class D (or OXA-type) β-lactamases have expanded to be the most diverse group of serine β-lactamases with a highly heterogeneous β-lactam hydrolysis profile and are typically resistant to marketed β-lactamase inhibitors. Class D enzymes are increasingly found in multidrug resistant (MDR) Acinetobacter baumannii, Pseudomonas aeruginosa, and various species of the Enterobacteriaceae and are posing a serious threat to the clinical utility of β-lactams including the carbapenems, which are typically reserved as the drugs of last resort. Avibactam, a novel non-β-lactam β-lactamase inhibitor, not only inhibits all class A and class C β-lactamases but also has the promise of inhibition of certain OXA enzymes, thus extending the antibacterial activity of the β-lactam used in combination to the organisms that produce these enzymes. X-ray structures of OXA-24 and OXA-48 in complex with avibactam revealed the binding mode of this inhibitor in this diverse class of enzymes and provides a rationale for selective inhibition of OXA-48 members. Additionally, various subunits of the OXA-48 structure in the asymmetric unit provide snapshots of different states of the inhibited enzyme. Overall, these data provide the first structural evidence of the exceptionally slow reversibility observed with avibactam in class D β-lactamases. Mechanisms for acylation and deacylation of avibactam by class D enzymes are proposed, and the likely extent of inhibition of class D β-lactamases by avibactam is discussed.
PubMed: 25406838
DOI: 10.1021/cb500703p
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.4 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon